# An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide

> **NIH NIH R42** · OUI THERAPEUTICS, INC · 2023 · $766,481

## Abstract

ABSTRACT
Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a
paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta
version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized
controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will
contribute to our understanding of the use of mobile technology as a suicide prevention tool.

## Key facts

- **NIH application ID:** 10601611
- **Project number:** 2R42MH125691-02
- **Recipient organization:** OUI THERAPEUTICS, INC
- **Principal Investigator:** Seth Feuerstein
- **Activity code:** R42 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $766,481
- **Award type:** 2
- **Project period:** 2021-02-15 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10601611

## Citation

> US National Institutes of Health, RePORTER application 10601611, An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide (2R42MH125691-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10601611. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*